Founded in 1994, Canadian Medical Discoveries Fund invests in the life sciences sector and is a labor-sponsored investment fund.
Canadian Medical Discoveries Fund (CMDF or the Fund) is a labour sponsored investment fund (LSIF), established in 1994, with venture capital investments in approximately 40 companies in the life sciences sector (mostly biotechnology, along with medical devices and health services companies).
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 2, 2009
Agrisoma Biosciences
|
Series Unknown | $2.32M | Biotechnology | — |
Sep 3, 2008
Natrix Separations
|
Series B | $19M | Biotechnology | — |
Jul 30, 2008
Cytochroma
|
Series C | $45M | Biotechnology | — |
Jul 3, 2008
Gemin X Pharmaceuticals
|
Series C | $38M | Biotechnology | — |
Jun 2, 2008
Inimex Pharmaceuticals
|
Series B | $22M | Biotechnology | — |
Canadian Medical Discoveries Fund has had 8 exits. Canadian Medical Discoveries Fund most notable exits include Natrix Separations , MethylGene
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Aug 28, 2017 | Natrix Separations | M&A | Biotechnology | Detail |
Jun 28, 2013 | MethylGene | M&A | Biopharma | Detail |
May 16, 2013 | Ambit Biosciences | M&A | Biopharma | Detail |
Jan 8, 2013 | Cytochroma | M&A | Biotechnology | Detail |
May 27, 2011 | Aegera Therapeutics | M&A | Biotechnology | Detail |